MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/cas.12760

Медицинская библиотека · Cancer science · 2015

Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?

Matsumoto Koji, Maeda Hiroo, Oki Akinori, Takatsuka Naoyoshi, Yasugi Toshiharu, Furuta Reiko, Hirata Ranko, Mitsuhashi Akira, Kawana Kei, Fujii Takuma, Iwata Takashi, Hirai Yasuo, Yokoyama Masatoshi, Yaegashi Nobuo, Watanabe Yoh, Nagai Yutaka, Yoshikawa Hiroyuki, Japan HPV and Cervical Cancer (JHACC) Study Group

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

We investigated the role of human leukocyte antigen (HLA) class II alleles in multistage cervical carcinogenesis. Cross-sectional analysis for HLA association with cervical cancer included 1253 Japanese women: normal cytology (NL, n = 341), cervical intraepithelial neoplasia grade 1 (CIN1, n = 505), CIN grade 2 or 3 (CIN2/3, n = 96), or invasive cervical cancer (ICC, n = 311). The HLA class II allele frequencies were compared by Fisher's exact test or the χ(2) -test. The Bonferroni adjustment corrected for multiple comparisons. Among the study subjects, 454 women with low-grade squamous intraepithelial lesion cytology were prospectively monitored by cytology and colposcopy every 3-4 months to analyze cumulative risk of CIN3 within the next 10 years in relation to HLA class II alleles. HLA class II DRB1*1302 allele frequency was similar between women with NL (11.7%) and CIN1 (11.9%), but significantly decreased to 5.2% for CIN2/3 and 5.8% for ICC (P = 0.0003). Correction for multiple testing did not change this finding. In women with low-grade squamous intraepithelial lesion cytology, the cumulative risk of CIN3 diagnosed within 10 years was significantly reduced among DRB1*1302-positive women (3.2% vs. 23.7%, P = 0.03). In conclusion, the two different types of analysis in this single study showed the protective effect of the DRB1*1302 allele against progression from CIN1 to CIN2/3.

Для цитирования: Matsumoto Koji, Maeda Hiroo, Oki Akinori, Takatsuka Naoyoshi, Yasugi Toshiharu, Furuta Reiko, Hirata Ranko, Mitsuhashi Akira, Kawana Kei, Fujii Takuma, Iwata Takashi, Hirai Yasuo, Yokoyama Masatoshi, Yaegashi Nobuo, Watanabe Yoh, Nagai Yutaka, Yoshikawa Hiroyuki, Japan HPV and Cervical Cancer (JHACC) Study Group. Human leukocyte antigen class II DRB1*1302 allele protects against cervical cancer: At which step of multistage carcinogenesis?. Cancer science. 2015. DOI: 10.1111/cas.12760.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.